4D Molecular Therapeutics
FDMT
FDMT
143 hedge funds and large institutions have $1.2B invested in 4D Molecular Therapeutics in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less capital invested
Capital invested by funds: $1.79B → $1.2B (-$590M)
74% less call options, than puts
Call options by funds: $1.19M | Put options by funds: $4.54M
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
143
Holding in Top 10
1
Calls
$1.19M
Puts
$4.54M
Top Buyers
| 1 | +$22.6M | |
| 2 | +$21.6M | |
| 3 | +$12.9M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$5.31M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.95M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$14.3M | |
| 3 | -$8.57M | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
-$7.96M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.44M |